TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.

David W Cescon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.